Anglikang (002940.SZ) obtained the registration certificate for the drug based on the Quixil tablet.

Zhtng Cijng APP news, Anglikang (002940.SZ) released an announcement. Recently, the company received the Drug Registration Certificate for Etoricoxib Tablets issued by the National Medical Products Administration (referred to as "NMPA"). Etoricoxib tablets are approved for treating symptoms and signs of acute and chronic osteoarthritis, acute gouty arthritis, and primary dysmenorrhea.